Cargando…

Cholesteryl Ester Transfer Protein Gene Polymorphisms and Longevity Syndrome

PURPOSE: High levels of high density lipoprotein (HDL) cholesterol are associated with a decreased risk of coronary heart disease (CHD). Subjects with high levels of HDL cholesterol (>70 mg/dl; 1.79 mmol/l) as well as high levels of low density lipoprotein (LDL) cholesterol, could represent a gro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kolovou, Genovefa, Stamatelatou, Marianna, Anagnostopoulou, Katherine, Kostakou, Peggy, Kolovou, Vana, Mihas, Constantinos, Vasiliadis, Ioannis, Diakoumakou, Olga, Mikhailidis, Dimitri P, Cokkinos, Dennis V
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831192/ https://www.ncbi.nlm.nih.gov/pubmed/20200605 http://dx.doi.org/10.2174/1874192401004010014

Ejemplares similares

Cholesteryl Ester Transfer Protein Gene and Effectiveness of Lipid Lowering of Atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2010)

Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia
por: Anagnostopoulou, Katherine K, et al.
Publicado: (2009)

The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease
por: Kolovou, Genovefa, et al.
Publicado: (2011)

CYP3A5 genotyping for assessing the efficacy of treatment with simvastatin and atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2015)

Biomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study
por: Kolovou, Vana, et al.
Publicado: (2018)

Five gene variants in nonagenarians, centenarians and average individuals
por: Kolovou, Vana, et al.
Publicado: (2017)

Impact of CYP3A5 Gene Polymorphism on Efficacy of Simvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2014)

The Link Between Human and Transgenic Animal Studies Involving Postprandial Hypertriglyceridemia and CETP Gene Polymorphisms
por: Kolovou, Genovefa D, et al.
Publicado: (2009)

Non-traumatic and non-drug-induced rhabdomyolysis
por: Kolovou, Genovefa, et al.
Publicado: (2019)

Severe/Extreme Hypertriglyceridemia and LDL Apheretic Treatment: Review of the Literature, Original Findings
por: Diakoumakou, Olga, et al.
Publicado: (2014)

Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy
por: Kolovou, Vana, et al.
Publicado: (2015)

Lipidomics in vascular health: current perspectives
por: Kolovou, Genovefa, et al.
Publicado: (2015)

Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia
por: Kolovou, Genovefa, et al.
Publicado: (2022)

Postprandial metabolic heterogeneity in men with primary dyslipidaemia
por: Pavlidis, Antonios N., et al.
Publicado: (2010)

We Are Ageing
por: Kolovou, Genovefa D., et al.
Publicado: (2014)

Low fasting low high-density lipoprotein and postprandial lipemia
por: Kolovou, Genovefa D, et al.
Publicado: (2004)

Platelet activating factor levels and metabolism in tangier disease: a case study
por: Kolovou, Vana, et al.
Publicado: (2012)

Fasting Serum Triglyceride and High-Density Lipoprotein Cholesterol Levels in Patients Intended to be Treated for Dyslipidemia
por: Kolovou, Genovefa D, et al.
Publicado: (2005)

ATP-binding cassette transporter A1 gene polymorphisms and serum lipid levels in young Greek nurses
por: Kolovou, Vana, et al.
Publicado: (2011)

Effect of ATP-binding Cassette Transporter A1 (ABCA1) Gene Polymorphisms on Plasma Lipid Variables and Common Demographic Parameters in Greek Nurses
por: Kolovou, Vana, et al.
Publicado: (2016)

Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects
por: Kolovou, Genovefa D, et al.
Publicado: (2005)

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
por: Chapman, M. John, et al.
Publicado: (2010)

Assessing the mechanisms of cholesteryl ester transfer protein inhibitors
por: Zhang, Meng, et al.
Publicado: (2017)

Association of gender, ABCA1 gene polymorphisms and lipid profile in Greek young nurses
por: Kolovou, Vana, et al.
Publicado: (2012)

Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
por: Goldberg, Alyse S, et al.
Publicado: (2012)

Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
por: Mabuchi, Hiroshi, et al.
Publicado: (2014)

Structure-based mechanism and inhibition of cholesteryl ester transfer protein
por: Xue, Han, et al.
Publicado: (2023)

Changes in Lipids and Lipoproteins after Selective LDL Apheresis (7-Year Experience)
por: Kolovou, Genovefa, et al.
Publicado: (2012)

Cholesteryl ester transfer protein TaqIB polymorphism and its association with serum lipid levels and longevity in Chinese Bama Zhuang population
por: Pan, Shang-Ling, et al.
Publicado: (2012)

Cholesteryl ester transfer protein: ace of spades, queen of hearts, or the joker?
por: Miller, Norman E.
Publicado: (2015)

REVEAL Study: Reveals the Limitations of Cholesteryl Ester Transfer Protein Inhibition
por: Pareek, Anil, et al.
Publicado: (2018)

The cholesteryl ester transfer protein (CETP) raises cholesterol levels in the brain
por: Oestereich, Felix, et al.
Publicado: (2022)

Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
por: Schmidt, Amand F., et al.
Publicado: (2021)

Impact of 3 Common ABCA1 Gene Polymorphisms on Optimal vs Non-Optimal Lipid Profile in Greek Young Nurses
por: Marvaki, Apostolia, et al.
Publicado: (2014)

Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases
por: Shinkai, Hisashi
Publicado: (2012)

Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
por: Duwensee, Kristina, et al.
Publicado: (2011)

The effect of cholesteryl ester transfer protein on pancreatic beta cell dysfunction in mice
por: Guo, Wen, et al.
Publicado: (2016)

Quinoline-3-carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors
por: Li, Wen-Yan, et al.
Publicado: (2012)

Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors
por: Wang, Ziyun, et al.
Publicado: (2017)

Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein
por: Ji, Ailing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_09r13pprjvkm39be8hagocrqg8